50
Participants
Start Date
November 4, 2016
Primary Completion Date
March 27, 2017
Study Completion Date
March 27, 2017
Symbicort pMDI with spacer device
Relative bioavailability of budesonide and formoterol delivered via Symbicort pressurized metered-dose inhaler (pMDI) with a spacer device (test)
Symbicort pMDI without spacer device
Relative bioavailability of budesonide and formoterol delivered via Symbicort pMDI without a spacer device (reference)
Research Site, Harrow
Lead Sponsor
Collaborators (1)
Parexel
INDUSTRY
AstraZeneca
INDUSTRY